CA
OGN icon

Continuum Advisory’s Organon & Co OGN Stock Holding History

Continuum Advisory’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.92K Buy
+142
New +$1.7K ﹤0.01% 1740
2025
Q2 		– Sell
-154
Closed -$2.29K – 1196
2025
Q1 		$2.29K Hold
154
– – ﹤0.01% 1310
2024
Q4 		$2.3K Hold
154
– – ﹤0.01% 1370
2024
Q3 		$2.36K Sell
154
-7
-4% -$145 ﹤0.01% 1375
2024
Q2 		$3.33K Hold
161
– – ﹤0.01% 1179
2024
Q1 		$3.3K Buy
+161
New +$2.76K ﹤0.01% 1159

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Continuum Advisory's OGN Position: Q2 2026 in Review

Continuum Advisory opened a new position in Organon & Co (OGN) in Q2 2026: 142 shares worth $1.92K. The stake represents ﹤0.01% of the portfolio and ranks #1740 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in OGN as recently as Q1 2025.

Continuum Advisory first reported a position in OGN in Q1 2024 and has held it in 6 quarters since. The position peaked at $3.33K in Q2 2024. 634 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Continuum Advisory held 142 shares of Organon & Co worth $1.92K as of Q2 2026.
  • Organon & Co was a new Continuum Advisory position in Q2 2026.
  • Organon & Co made up ﹤0.01% of Continuum Advisory's portfolio in Q2 2026, its #1740 holding.
  • Continuum Advisory first reported a position in Organon & Co in Q1 2024 and has held it in 6 quarters since.
  • Continuum Advisory's Organon & Co position peaked at $3.33K in Q2 2024.
  • 634 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.